Zydus Lifesciences Limited · NSE: ZYDUSLIFE · BSE: 532321
Zydus Lifesciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 11 Aug 2026.
Q1 FY27 · Consolidated
Revenue
8,017.00₹ Cr
+22.0% vs year ago
Net profit
990.20₹ Cr
−34.9% vs year ago
EPS, basic
9.35₹
−35.9% vs year ago
Net margin
12.4%
−10.8 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 8,017.00 | +22.0% | 990.20 | −34.9% | 9.35 | 11 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 7,587.00 | +16.2% | 1,341.00 | +7.8% | 12.65 | 19 May 2026 |
| Q3 FY26Oct–Dec 2025 | 6,864.50 | +30.3% | 1,022.90 | −0.3% | 10.36 | 09 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 6,123.20 | +16.9% | 1,238.60 | +34.6% | 12.51 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 6,573.70 | +5.9% | 1,521.00 | +2.6% | 14.58 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 6,527.90 | +18.0% | 1,243.70 | −0.2% | 11.64 | 20 May 2025 |
| Q3 FY25Oct–Dec 2024 | 5,269.10 | +17.0% | 1,026.20 | +29.9% | 10.17 | 05 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 5,237.00 | +19.9% | 920.20 | +14.6% | 9.06 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 6,207.50 | +20.8% | 1,482.50 | +30.8% | 14.11 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 5,533.80 | +10.4% | 1,246.10 | +247.9% | 11.69 | 18 May 2024 |
| Q3 FY24Oct–Dec 2023 | 4,505.20 | +3.3% | 789.90 | +25.1% | 7.80 | 10 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 4,368.80 | +5.7% | 803.20 | +52.7% | 7.91 | 09 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 5,139.60 | +26.2% | 1,133.60 | +96.7% | 10.74 | 11 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 5,010.60 | +29.7% | 358.20 | −21.0% | 2.93 | 19 May 2023 |
| Q3 FY23Oct–Dec 2022 | 4,362.30 | +19.4% | 631.20 | +23.6% | 6.15 | 03 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 4,134.70 | +9.2% | 526.10 | −82.5% | 5.15 | 12 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 4,072.70 | +1.2% | 576.40 | −10.3% | 5.06 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 3,863.80 | +0.4% | 453.30 | −38.4% | 3.88 | 20 May 2022 |
| Q3 FY22Oct–Dec 2021 | 3,655.00 | −3.7% | 510.60 | −3.3% | 4.89 | 03 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 3,784.80 | −0.9% | 3,011.90 | +592.4% | 29.32 | 29 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 4,025.40 | +10.6% | 642.50 | +32.0% | 5.74 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 3,846.70 | +2.5% | 735.40 | +77.8% | 6.63 | 27 May 2021 |
| Q3 FY21Oct–Dec 2020 | 3,795.60 | +4.3% | 528.00 | +42.2% | 5.15 | 05 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 3,820.00 | +13.5% | 435.00 | +362.8% | 4.62 | 02 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 3,639.90 | +4.1% | 486.60 | +49.6% | 4.43 | 05 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 3,752.10 | +0.5% | 413.70 | −14.1% | 3.83 | 19 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 3,638.10 | +1.7% | 371.40 | −28.8% | 3.65 | 05 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 3,366.60 | +13.7% | 94.00 | −78.0% | 1.05 | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 3,496.30 | +20.8% | 325.30 | −30.4% | 2.97 | 09 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 3,732.80 | — | 481.70 | — | 4.49 | 29 May 2019 |
| Q3 FY19Oct–Dec 2018 | 3,577.90 | — | 521.60 | — | 4.99 | 07 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 2,961.20 | — | 428.20 | — | 4.08 | 03 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 2,893.70 | — | 467.20 | — | 4.50 | 13 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 2,872.20 | +11.0% | 339.60 | −11.7% | 3.38 | 11 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 3,740.90 | −35.7% | 1,722.00 | −38.8% | 17.11 | 19 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2,283.60 | −9.2% | 296.50 | −37.0% | 2.95 | 09 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 2,871.20 | +9.6% | 1,156.60 | +46.4% | 11.49 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 2,588.30 | −37.8% | 384.70 | −77.4% | 3.82 | 12 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 5,819.60 | +74.6% | 2,813.70 | +100.2% | 27.96 | 20 May 2025 |
| Q3 FY25Oct–Dec 2024 | 2,515.90 | +6.1% | 470.60 | +4.5% | 4.68 | 05 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 2,620.60 | +21.4% | 789.80 | −1.9% | 7.85 | 12 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 4,160.20 | +40.8% | 1,700.80 | +117.8% | 16.90 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 3,332.40 | +29.2% | 1,405.20 | +186.4% | 13.89 | 18 May 2024 |
| Q3 FY24Oct–Dec 2023 | 2,371.30 | +13.6% | 450.40 | +76.0% | 4.45 | 10 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 2,159.30 | −10.0% | 805.00 | +78.5% | 7.96 | 09 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 2,955.70 | +49.2% | 780.90 | +135.6% | 7.71 | 11 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 2,579.30 | +27.7% | 490.70 | +98.7% | 4.85 | 19 May 2023 |
| Q3 FY23Oct–Dec 2022 | 2,086.90 | +14.0% | 255.90 | +29.9% | 2.53 | 03 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 2,398.80 | +19.4% | 451.10 | 32x | 4.45 | 12 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 1,980.90 | −6.7% | 331.50 | −17.1% | 3.24 | 11 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 2,019.30 | +0.0% | 246.90 | −46.9% | 2.41 | 20 May 2022 |
| Q3 FY22Oct–Dec 2021 | 1,830.30 | −4.6% | 197.00 | +40.4% | 1.92 | 03 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 2,008.90 | −2.3% | 14.10 | −97.0% | 0.14 | 29 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 2,123.40 | +18.2% | 399.90 | +0.4% | 3.91 | 11 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 2,018.80 | +11.4% | 464.70 | −25.0% | 4.54 | 27 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1,918.80 | +3.8% | 140.30 | −50.2% | 1.37 | 05 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 2,056.90 | +22.2% | 473.00 | −24.7% | 4.62 | 02 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 1,795.90 | +33.6% | 398.20 | +406.0% | 3.89 | 05 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 1,812.20 | +8.7% | 619.30 | +136.3% | 6.05 | 19 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 1,848.60 | +10.3% | 281.60 | −22.5% | 2.75 | 05 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 1,682.70 | +2.3% | 627.90 | −5.8% | 6.13 | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 1,343.80 | −10.7% | 78.70 | −74.6% | 0.77 | 09 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 1,667.80 | — | 262.10 | — | 2.56 | 29 May 2019 |
| Q3 FY19Oct–Dec 2018 | 1,675.50 | — | 363.30 | — | 7.10 | 07 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 1,644.50 | — | 666.50 | — | 6.51 | 03 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 1,504.90 | — | 310.20 | — | 3.03 | 13 Aug 2018 |
66 filings on record for this company.